The application of its zinc finger nuclease (ZFN) gene-editing technology in hematopoietic stem cells (HSCs) will be leveraged in the development of potentially curative ZFP Therapeutic. Funds required
Launch of the new application, especially for mothers, was based on a survey that noted more than half of parents were worried of incorrectly identifying their child’s symptoms
Novo chief scientific officer Mads Thomsen was quoted by health24.com as saying that liraglutide treatment was likely to be launched in the US at the end of next
Postmenopausal women with locally advanced or metastatic estrogen receptor positive (ER+) and/or progesterone receptor positive (PR+), HER2-negative breast cancer are participating in the randomized, double blind trial. Merrimack
As per terms of the deal, BTG is expected to gain TheraSphere, which is the sole targeted liver cancer therapy product of Targeted Therapies business that is manufactured
A total of 120 individuals are expected to be included in the double-blind, multicenter study designed to assess the safety and efficacy profile of UC1010. Umecrine Mood CEO
The application covers the use of Abraxane and gemcitabine combination therapy for the front line treatment of patients with advanced pancreatic cancer. In April 2013, the European Medicines
The certificate is granted for the company’s proprietary vaccines, Haidian district bulk production plants, and Changping filing and packaging facility. Sinovac chairman, president and CEO Dr. Weidong YIN
Under the partnership, the college will support the development of new and commercial delivery forms of low dose Naltrexone in the form of oral capsules and tablets and
The company has also upgraded its systems to provide current good manufacturer practices (cGMP)-level quality in its home delivery pharmacy in Sioux Falls, South Dakota to prevent deviations,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.